Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced the results of its Annual and Special Meeting of shareholders (the "Shareholders") held on June 8, 2026 (the "Meeting"). The Company confirms that all resolutions put forward in the Management Information Circular dated April 27, 2026 (the "Circular") to its Shareholders were approved.

Results of the matters voted on at the Meeting are set out below.

Election of Directors

Spectral's seven director nominees were elected:

Nominee	Votes For (percent)	Votes Withheld (percent)
Jan D'Alvise	98.51%	1.49%
Jun Hayakawa	99.83%	0.17%
Chris Seto	83.50%	16.50%
William Stevens	99.61%	0.39%
Paul Walker	94.28%	5.72%
David W. Feigal, Jr.	99.41%	0.59%
Cristiano Franzi	98.80%	1.20%

Appointment of Auditors

MNP LLP, Chartered Professional Accountants, was re-appointed as auditor of Spectral.

Votes For: 99.96%

Votes Withheld: 0.04%

Adoption of Omnibus Long Term Incentive Plan

A resolution approving the re-adoption of the Corporation’s omnibus long term incentive plan, as more particularly described in the Circular was passed.

Votes For: 84.39%

Votes Against: 15.61%

Approval of Consolidation

A special resolution authorizing the future amendment of the articles of the Company to consolidate all of the Company's issued and outstanding common shares (the "Shares"), on the basis of a consolidation ratio in the range of 1 post-consolidation Share for 5 pre-consolidation Shares to 1 post-consolidation Share for 10 pre-consolidation Shares to be selected by the board of directors of the Corporation (the "Board"), at such time as the Board so determines within 12 months of the date of the Meeting, was approved.

Schreibe Deinen Kommentar